Concepts (111)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pancreatic Neoplasms | 6 | 2023 | 206 | 3.700 |
Why?
|
| Carcinoma, Pancreatic Ductal | 4 | 2023 | 60 | 2.930 |
Why?
|
| Genome-Wide Association Study | 9 | 2024 | 421 | 2.490 |
Why?
|
| Alzheimer Disease | 5 | 2024 | 972 | 2.360 |
Why?
|
| Blood Proteins | 5 | 2024 | 75 | 2.300 |
Why?
|
| Genetic Predisposition to Disease | 7 | 2024 | 727 | 2.140 |
Why?
|
| DNA Methylation | 6 | 2023 | 393 | 2.080 |
Why?
|
| Polymorphism, Single Nucleotide | 7 | 2024 | 860 | 1.660 |
Why?
|
| Neurodegenerative Diseases | 2 | 2023 | 138 | 1.470 |
Why?
|
| Prostatic Neoplasms | 3 | 2023 | 1068 | 1.090 |
Why?
|
| Digoxin | 2 | 2017 | 10 | 1.010 |
Why?
|
| Mendelian Randomization Analysis | 2 | 2023 | 11 | 0.890 |
Why?
|
| Depsipeptides | 1 | 2024 | 8 | 0.860 |
Why?
|
| Genetic Association Studies | 2 | 2021 | 118 | 0.830 |
Why?
|
| Metabolomics | 1 | 2024 | 90 | 0.810 |
Why?
|
| Alleles | 2 | 2021 | 352 | 0.760 |
Why?
|
| Esophageal Neoplasms | 1 | 2024 | 137 | 0.760 |
Why?
|
| Humans | 28 | 2025 | 42163 | 0.760 |
Why?
|
| Genomics | 1 | 2024 | 289 | 0.720 |
Why?
|
| Case-Control Studies | 5 | 2024 | 1266 | 0.690 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2020 | 12 | 0.680 |
Why?
|
| Risk Factors | 6 | 2024 | 3942 | 0.620 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2024 | 744 | 0.620 |
Why?
|
| Promoter Regions, Genetic | 3 | 2017 | 534 | 0.580 |
Why?
|
| CpG Islands | 4 | 2023 | 107 | 0.570 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2020 | 933 | 0.530 |
Why?
|
| Male | 13 | 2025 | 22779 | 0.430 |
Why?
|
| Pancreas | 2 | 2023 | 45 | 0.410 |
Why?
|
| Metabolome | 2 | 2024 | 50 | 0.400 |
Why?
|
| Epigenesis, Genetic | 1 | 2015 | 274 | 0.380 |
Why?
|
| Models, Genetic | 2 | 2020 | 181 | 0.320 |
Why?
|
| Transcription Factors | 2 | 2024 | 722 | 0.300 |
Why?
|
| Aged | 5 | 2024 | 7982 | 0.280 |
Why?
|
| Middle Aged | 6 | 2024 | 11819 | 0.280 |
Why?
|
| Signal Transduction | 3 | 2024 | 2111 | 0.260 |
Why?
|
| Chromatin | 2 | 2024 | 179 | 0.230 |
Why?
|
| Genotype | 2 | 2019 | 796 | 0.220 |
Why?
|
| Female | 7 | 2025 | 24018 | 0.220 |
Why?
|
| Apoptosis | 3 | 2024 | 1541 | 0.220 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2024 | 52 | 0.210 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2023 | 66 | 0.210 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2025 | 130 | 0.210 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2023 | 25 | 0.200 |
Why?
|
| RNA Splicing | 1 | 2023 | 42 | 0.200 |
Why?
|
| Canada | 1 | 2023 | 157 | 0.200 |
Why?
|
| RNA, Small Interfering | 1 | 2025 | 436 | 0.200 |
Why?
|
| Cell Adhesion Molecules | 1 | 2023 | 84 | 0.200 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2024 | 339 | 0.190 |
Why?
|
| Prognosis | 2 | 2024 | 850 | 0.190 |
Why?
|
| Resorcinols | 1 | 2021 | 4 | 0.180 |
Why?
|
| Cell Line, Tumor | 4 | 2024 | 2598 | 0.180 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2023 | 222 | 0.180 |
Why?
|
| Severity of Illness Index | 2 | 2021 | 708 | 0.180 |
Why?
|
| Proteomics | 1 | 2024 | 363 | 0.180 |
Why?
|
| Organ Specificity | 1 | 2021 | 141 | 0.180 |
Why?
|
| Chromosome Mapping | 1 | 2021 | 198 | 0.170 |
Why?
|
| Databases, Genetic | 1 | 2021 | 103 | 0.170 |
Why?
|
| Repressor Proteins | 1 | 2023 | 267 | 0.170 |
Why?
|
| Longitudinal Studies | 1 | 2023 | 1020 | 0.160 |
Why?
|
| Lung Neoplasms | 1 | 2025 | 479 | 0.160 |
Why?
|
| Cell Proliferation | 2 | 2024 | 1420 | 0.160 |
Why?
|
| Computational Biology | 1 | 2021 | 324 | 0.150 |
Why?
|
| Neoplasms | 2 | 2024 | 1341 | 0.150 |
Why?
|
| Phenotype | 1 | 2021 | 774 | 0.140 |
Why?
|
| Gene Expression | 1 | 2021 | 692 | 0.140 |
Why?
|
| Models, Biological | 1 | 2021 | 711 | 0.140 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 683 | 0.140 |
Why?
|
| Age Factors | 1 | 2020 | 1139 | 0.130 |
Why?
|
| Artemisinins | 1 | 2017 | 19 | 0.130 |
Why?
|
| Haplotypes | 1 | 2017 | 197 | 0.130 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 1066 | 0.120 |
Why?
|
| Glioma | 1 | 2017 | 92 | 0.120 |
Why?
|
| Adult | 5 | 2023 | 13458 | 0.120 |
Why?
|
| Isothiocyanates | 1 | 2015 | 20 | 0.120 |
Why?
|
| Acetylation | 1 | 2015 | 108 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2017 | 297 | 0.110 |
Why?
|
| Anticarcinogenic Agents | 1 | 2015 | 74 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 1112 | 0.110 |
Why?
|
| Histones | 1 | 2015 | 194 | 0.100 |
Why?
|
| Organic Cation Transport Proteins | 1 | 2013 | 13 | 0.100 |
Why?
|
| RNA, Messenger | 2 | 2015 | 1265 | 0.100 |
Why?
|
| Mice | 1 | 2024 | 6490 | 0.100 |
Why?
|
| Epithelial Cells | 1 | 2015 | 426 | 0.090 |
Why?
|
| MicroRNAs | 1 | 2017 | 501 | 0.090 |
Why?
|
| Animals | 3 | 2024 | 16695 | 0.080 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 979 | 0.060 |
Why?
|
| Young Adult | 1 | 2015 | 4936 | 0.050 |
Why?
|
| Adolescent | 1 | 2015 | 5950 | 0.050 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2024 | 61 | 0.050 |
Why?
|
| Melanoma | 1 | 2024 | 109 | 0.050 |
Why?
|
| Colonic Neoplasms | 1 | 2024 | 223 | 0.040 |
Why?
|
| China | 1 | 2020 | 233 | 0.040 |
Why?
|
| Comorbidity | 1 | 2020 | 725 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2020 | 1586 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 366 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2020 | 2485 | 0.030 |
Why?
|
| Azacitidine | 1 | 2013 | 22 | 0.030 |
Why?
|
| Organoplatinum Compounds | 1 | 2013 | 18 | 0.030 |
Why?
|
| COS Cells | 1 | 2013 | 67 | 0.030 |
Why?
|
| Luciferases | 1 | 2013 | 70 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2015 | 348 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2013 | 148 | 0.030 |
Why?
|
| Cell Movement | 1 | 2017 | 640 | 0.020 |
Why?
|
| Genome, Human | 1 | 2013 | 143 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2013 | 454 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2015 | 355 | 0.020 |
Why?
|
| Base Sequence | 1 | 2013 | 997 | 0.020 |
Why?
|
| Mitochondria | 1 | 2015 | 516 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 1559 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2013 | 599 | 0.020 |
Why?
|
| Cell Survival | 1 | 2013 | 934 | 0.020 |
Why?
|